Vanguard Group
BCAX

Vanguard Group’s Bicara Therapeutics Inc. Common Stock BCAX Stock Holding History

Vanguard Group’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$18.6M Buy
2,005,258
+914,140
+84% +$8.49M ﹤0.01% 2590
2025
Q1 		$14.2M Buy
1,091,118
+590
+0.1% +$7.69K ﹤0.01% 2660
2024
Q4 		$19M Buy
1,090,528
+1,020,528
+1,458% +$17.8M ﹤0.01% 2613
2024
Q3 		$1.78M Buy
+70,000
New +$1.78M ﹤0.01% 3595